N-acetylcysteine (NAC)
N-acetylcysteine (NAC) is a dietary supplement with 31 clinical trials. Currently 3 active trials ongoing. Historical success rate of 95.2%.
Success Metrics
Based on 20 completed trials
Phase Distribution
Phase Distribution
6
Early Stage
15
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.2%
20 of 21 finished
4.8%
1 ended early
3
trials recruiting
31
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)
Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
Glutathione in Mild Cognitive Impairment
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome
Clinical Trials (31)
Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)
Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1
Glutathione in Mild Cognitive Impairment
The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia
Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome
N-acetylcysteine for Root Canal Treatment of Necrotic Teeth With Apical Periodontitis
N-Acetylcysteine Roles in Preserving Renal Function Measured by Urinary KIM-1 (Kidney Injury Molecule-1) and Serum Creatinine on Cancer Patients With Cisplatin Based Chemotherapy: A Randomized Placebo-Controlled Trial
The Anti-Anginal Effects of N-Acetylcysteine (NAC) in Patients with Angina and Non-Obstructive Coronary Arteries (ANOCA)
N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
RENACTIF: Reduction of the Thrombotic Phenotype in Renal Insufficiency With N-AcetylCysteine
Translational Neuropsychopharmacology Research of Nicotine Addiction
Clinical Trial With N-acetylcysteine and Bromhexine for COVID-19
A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers
N-acetylcysteine for Tobacco Use Disorder
A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)
Pharmacological Prophylaxis of Post- Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
Use of N-Acetylcysteine (NAC) in Fingernail Biting
N-Acetyl Cysteine and Aspirin as an Adjunctive Treatment for Bipolar Disorder
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
The Impact of N-Acetylcysteine on Volumetric Retention of Autologous Fat Graft for Breast Asymmetry Correction
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 31